NCT03787017View on ClinicalTrials.gov

A Study to Compare MP-513 20mg & Metformin XR 1000mg FDC With Coadministration of the Two Separate Drugs

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

September 30, 2014

Conditions
Healthy Volunteers
Interventions
DRUG

FDC(MP-513 20mg/Metformin XR 1000mg)

DRUG

MP-513 20mg

DRUG

Metformin XR 1000mg

Trial Locations (1)

301-721

Clinical trials center of Chungnam National University Hospital, Daejeon

Sponsors

Lead Sponsor

Handok Inc.
All Listed Sponsors
lead

Handok Inc.

INDUSTRY

NCT03787017 - A Study to Compare MP-513 20mg & Metformin XR 1000mg FDC With Coadministration of the Two Separate Drugs | Biotech Hunter | Biotech Hunter